600645

Vcanbio Cell & Gene Engineering Corp., Ltd

CN Healthcare Biotechnology

Latest week
17 Jul 2026
Close
17.850000
Fair value
21.223013
Next-week expectancy
Negative 44.91%
Sharemaestro

600645 Chart Pack

Vcanbio Cell & Gene Engineering Corp., Ltd

Exchange
SHH
Latest week
17 Jul 2026
Close
17.850000
Fair value
21.223013
Next-week expectancy
Negative 44.91%
Generated
21 Jul 2026 21:10
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-17, 600645 fell 31.00%, moving from 25.87 to 17.85. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 1 of the last 12 weeks. Relative Strength is -25.82 and has softened across the 12-week window. Market Dynamics is -1.01 on the latest week. Next-week expectancy is negative at 44.91% based on similar historical setup states.

Key Points

Week Ending
17 Jul 2026
Latest Close
17.85
12-Week Change
-31.00%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.91%
Signal Weeks
1 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-25.82
Market Dynamics
-1.01

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
17 Jul 2026
Latest Close
17.85
12-Week Change
-31.00%
Trend Signal
Inactive
Next-Week Expectancy
Negative 44.91%
Signal Weeks
1 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-25.82
Market Dynamics
-1.01

Over the latest 12 completed weeks ending 2026-07-17, 600645 fell 31.00%, moving from 25.87 to 17.85. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 1 of the last 12 weeks. Relative Strength is -25.82 and has softened across the 12-week window. Market Dynamics is -1.01 on the latest week. Next-week expectancy is negative at 44.91% based on similar historical setup states.

Industry Peers

China equities in Biotechnology

Stock Exchange Week Open High Low Close Change
688166 BrightGene Bio-Medical Technology Co., Ltd. SHH 17 Jul 2026 31.01 42.52 28.74 38.48 24.09%
300255 Hebei Changshan Biochemical Pharmaceutical Co., Ltd. SHZ 17 Jul 2026 26.88 34.00 23.35 31.76 18.15%
603896 Zhejiang Shouxiangu Pharmaceutical Co., Ltd. SHH 17 Jul 2026 13.86 15.99 13.80 15.58 12.41%
002252 Shanghai RAAS Blood Products Co., Ltd. SHZ 17 Jul 2026 4.61 5.23 4.57 5.09 10.41%
688488 Jiangsu Aidea Pharmaceutical Group Co., Ltd. SHH 17 Jul 2026 14.09 18.58 13.91 15.36 9.01%
600866 Star Lake Bioscience Co., Inc.Zhaoqing Guangdong SHH 17 Jul 2026 4.62 5.10 4.56 5.01 8.44%
300149 ChemPartner PharmaTech Co.,Ltd. SHZ 17 Jul 2026 8.91 11.40 8.19 9.66 8.42%
603590 Beijing Konruns Pharmaceutical Co.,Ltd. SHH 17 Jul 2026 31.63 37.93 31.63 34.21 8.16%
000504 Landfar Bio-medicine Co., Ltd SHZ 17 Jul 2026 7.98 9.36 7.58 8.55 7.14%
688293 Shanghai OPM Biosciences Co., Ltd. SHH 17 Jul 2026 48.51 58.99 45.61 51.82 6.82%
300294 China Resources Boya Bio-pharmaceutical Group Co.,Ltd SHZ 17 Jul 2026 14.70 16.36 14.60 15.66 6.53%
000403 Pacific Shuanglin Bio-pharmacy Co., Ltd. SHZ 17 Jul 2026 9.16 10.21 9.11 9.73 6.22%
688759 BEBETTER MED INC SHH 17 Jul 2026 31.54 36.79 30.70 33.33 5.68%
603566 Pulike Biological Engineering, Inc. SHH 17 Jul 2026 10.17 11.13 10.10 10.70 5.21%
688796 BIOCYTOGEN PHARMACEUTICALS (BEI SHH 17 Jul 2026 112.40 154.99 107.30 117.00 4.09%
300759 Pharmaron Beijing Co., Ltd. SHZ 17 Jul 2026 34.15 42.00 32.15 35.48 3.89%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.